Skip to content

Drug interactions

Lomustine + Thiotepa

Severity: Major

Lomustine and Thiotepa: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both agents are alkylating cytotoxics with dose-limiting bone marrow toxicity. Used together they can produce deeper and longer-lasting neutropenia, thrombocytopenia and anemia, raising the risk of infection and bleeding.

What this interaction means in plain words

Lomustine and Thiotepa can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Lomustine belongs to Oncology; Thiotepa belongs to Oncology.

Evidence level: Moderate

Why it happens

Additive pharmacodynamic myelosuppression from two DNA-alkylating agents.

What to do

Monitor complete blood counts frequently, including the nadir period, and reduce doses or delay cycles for marked cytopenias. Provide supportive care such as growth factors and transfusion as indicated.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lomustine and Thiotepa, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Lomustine with Thiotepa?

MediHelp rates the interaction as major. Lomustine and Thiotepa can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both agents are alkylating cytotoxics with dose-limiting bone marrow toxicity. Used together they can produce deeper and longer-lasting neutropenia, thrombocytopenia and anemia, raising the risk of infection and bleeding.

How serious is the interaction between Lomustine and Thiotepa?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor complete blood counts frequently, including the nadir period, and reduce doses or delay cycles for marked cytopenias. Provide supportive care such as growth factors and transfusion as indicated.

What other medicines interact with Lomustine?

MediHelp also lists interactions of Lomustine with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal. The full list is on the Lomustine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in